EyePoint, Inc. Costs and Expenses
EyePoint, Inc. (EYPT) reported Costs and Expenses of $43.27 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2024-11-07
- EyePoint, Inc. costs and expenses for the quarter ending 2024-09-30 was $43.27M, a 46.19% increase year-over-year.
- EyePoint, Inc. costs and expenses for the quarter ending 2024-06-30 was $44.02M, a 38.15% increase year-over-year.
- EyePoint, Inc. costs and expenses for the quarter ending 2024-03-31 was $45.01M, a 53.93% increase year-over-year.
- EyePoint, Inc. costs and expenses for the quarter ending 2023-09-30 was $29.60M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month |
|---|---|---|---|
| 2024-09-30 | $43.27M 10-Q · filed 2024-11-07 | $87.30M derived: sum of 2 quarters · filed 2024-11-07 | $132.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $44.02M 10-Q · filed 2024-08-08 | $89.03M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $45.01M 10-Q · filed 2024-05-09 | ||
| 2023-09-30 | $29.60M 10-Q · filed 2024-11-07 | $61.47M derived: sum of 2 quarters · filed 2024-11-07 | $90.70M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $31.87M 10-Q · filed 2024-08-08 | $61.10M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $29.24M 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |